ENP20: Burosumab
We look into promising findings from clinical trials regarding Burosumab, a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia. With us are Erik Imel, MD from the Indiana University School of Medicine and Suzanne Marie Jan De Beur, MD from Johns Hopkins University School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Endocrine News Podcast?
This episode is 18 minutes long.
When was this Endocrine News Podcast episode published?
This episode was published on May 29, 2019.
Can I download this Endocrine News Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.